Figure 3.
Correlations between baseline biomarkers and clinical decline in ALS. (A, B) Higher baseline NfL levels (pg/mL) are associated with greater monthly decline in slow vital capacity (Δ sVC %/month) and ALSFRS-R (Δ ALSFRS-R/month), respectively. (C, D) Higher baseline MUNIX-10 scores are associated with slower decline in ALSFRS-R (D), but show no significant association with Δ SVC (C). The most pronounced correlations were found for baseline NfL/MUNIX-10 ratio with Δ SVC (E) and Δ ALSFRS-R (F). Each panel shows individual data points, linear regression lines (blue), 95% confidence intervals (gray shading), and corresponding Spearman correlation coefficients (rho) with p-values adjusted for multiplicity by Bonferroni-Holm.
